FDA Clearance Tracker · K260474
Liora Monofilament Scaffold
Last checked: Nov 19, 2026Latest source record: Sep 28, 2026 (this decision)Source: openFDAMethods & limitations
Decided
Sep 28, 2026
Substantially Equivalent
Time to decision
228 days
Received Feb 12, 2026. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K260474
- Device name
- Liora Monofilament Scaffold
- Applicant
- TELA Bio, Inc.
- Applicant location
- Malvern, PA
- Received
- Feb 12, 2026
- Decided
- Sep 28, 2026
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device type
- Mesh, Surgical, Polymeric (FTL)
- Device class
- Class II
- Regulation
- 21 CFR 878.3300
- Specialty
- General & Plastic Surgery
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code FTL. The earliest in FDA's data is K792281, decided Nov 27, 1979.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K260474
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for TELA Bio, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K243595 · Decided Dec 19, 2024 · 29 days after receipt
Device type: Mesh, Surgical (FTM) · General & Plastic Surgery
- OviTex PRS510(k)
K241126 · Decided May 22, 2024 · 29 days after receipt
Device type: Mesh, Surgical (FTM) · General & Plastic Surgery
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.